Proceedings from the NIMH symposium on “NeuroAIDS in Africa: neurological and neuropsychiatric complications of HIV”

Shilpa J Buch, Ernest T. Chivero, Jackie Hoare, Jibreel Jumare, Noeline Nakasujja, Victor Mudenda, Robert Paul, Georgette D Kanmogne, Ned Sacktor, Charles Wood, Walter Royal, Jeymohan Joseph

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Despite major advances in HIV-1 treatment, the prevalence of HIV-associated neurocognitive disorders (HAND) remains a problem, particularly as individuals on suppressive treatment continue to live longer. To facilitate discussion on emerging and future directions in HAND research, a meeting was held in Durban, South Africa in March 2015 as part of the Society of Neuroscientists of Africa (SONA) conference. The objective of the meeting was to assess the impact of HIV subtype diversity on HAND and immunological dysfunction. The meeting brought together international leaders in the area of neurological complications of HIV-1 infection with special focus on the African population. Research presentations indicated that HAND was highly prevalent and that inflammatory cytokines and immune-activation played important roles in progression of neurocognitive impairment. Furthermore, children on antiretroviral therapy were also at risk for developing neurocognitive impairment. With respect to the effect of HIV-1 subtype diversity, analyses of HIV-1 clade C infection among South Africans revealed that clade C infection induced cognitive impairment that was independent of the substitution in HIV-1 Trans-Activator of Transcription (Tat; C31S). At the cellular level, a Zambian study showed that clade C infection resulted in reduced brain cell death compared with clade B infection suggesting clade specific variations in mediating brain cell injury. Furthermore, ex vivo Tat protein from clade CRF02_AG, prevalent in West/ Central Africa, exhibited reduced disruption of brain endothelium compared with clade B Tat protein. Discussions shed light on future research directions aimed at understanding biomarkers and disease mechanisms critical for HAND.

Original languageEnglish (US)
Pages (from-to)699-702
Number of pages4
JournalJournal of neurovirology
Volume22
Issue number5
DOIs
StatePublished - Oct 1 2016

Fingerprint

National Institute of Mental Health (U.S.)
HIV-1
HIV
tat Gene Products
Infection
Central Africa
Western Africa
Brain Death
Trans-Activators
South Africa
Research
Brain Injuries
HIV Infections
Endothelium
Cell Death
Therapeutics
Biomarkers
Neurocognitive Disorders
Cytokines
Brain

Keywords

  • HIV-associated neurocognitive disorders (HAND)
  • Human immunodeficiency virus (HIV)
  • NeuroAIDS

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Virology

Cite this

Proceedings from the NIMH symposium on “NeuroAIDS in Africa : neurological and neuropsychiatric complications of HIV”. / Buch, Shilpa J; Chivero, Ernest T.; Hoare, Jackie; Jumare, Jibreel; Nakasujja, Noeline; Mudenda, Victor; Paul, Robert; Kanmogne, Georgette D; Sacktor, Ned; Wood, Charles; Royal, Walter; Joseph, Jeymohan.

In: Journal of neurovirology, Vol. 22, No. 5, 01.10.2016, p. 699-702.

Research output: Contribution to journalArticle

Buch, SJ, Chivero, ET, Hoare, J, Jumare, J, Nakasujja, N, Mudenda, V, Paul, R, Kanmogne, GD, Sacktor, N, Wood, C, Royal, W & Joseph, J 2016, 'Proceedings from the NIMH symposium on “NeuroAIDS in Africa: neurological and neuropsychiatric complications of HIV”', Journal of neurovirology, vol. 22, no. 5, pp. 699-702. https://doi.org/10.1007/s13365-016-0467-y
Buch, Shilpa J ; Chivero, Ernest T. ; Hoare, Jackie ; Jumare, Jibreel ; Nakasujja, Noeline ; Mudenda, Victor ; Paul, Robert ; Kanmogne, Georgette D ; Sacktor, Ned ; Wood, Charles ; Royal, Walter ; Joseph, Jeymohan. / Proceedings from the NIMH symposium on “NeuroAIDS in Africa : neurological and neuropsychiatric complications of HIV”. In: Journal of neurovirology. 2016 ; Vol. 22, No. 5. pp. 699-702.
@article{d2eefe876b7445adb39926a0e276f37b,
title = "Proceedings from the NIMH symposium on “NeuroAIDS in Africa: neurological and neuropsychiatric complications of HIV”",
abstract = "Despite major advances in HIV-1 treatment, the prevalence of HIV-associated neurocognitive disorders (HAND) remains a problem, particularly as individuals on suppressive treatment continue to live longer. To facilitate discussion on emerging and future directions in HAND research, a meeting was held in Durban, South Africa in March 2015 as part of the Society of Neuroscientists of Africa (SONA) conference. The objective of the meeting was to assess the impact of HIV subtype diversity on HAND and immunological dysfunction. The meeting brought together international leaders in the area of neurological complications of HIV-1 infection with special focus on the African population. Research presentations indicated that HAND was highly prevalent and that inflammatory cytokines and immune-activation played important roles in progression of neurocognitive impairment. Furthermore, children on antiretroviral therapy were also at risk for developing neurocognitive impairment. With respect to the effect of HIV-1 subtype diversity, analyses of HIV-1 clade C infection among South Africans revealed that clade C infection induced cognitive impairment that was independent of the substitution in HIV-1 Trans-Activator of Transcription (Tat; C31S). At the cellular level, a Zambian study showed that clade C infection resulted in reduced brain cell death compared with clade B infection suggesting clade specific variations in mediating brain cell injury. Furthermore, ex vivo Tat protein from clade CRF02_AG, prevalent in West/ Central Africa, exhibited reduced disruption of brain endothelium compared with clade B Tat protein. Discussions shed light on future research directions aimed at understanding biomarkers and disease mechanisms critical for HAND.",
keywords = "HIV-associated neurocognitive disorders (HAND), Human immunodeficiency virus (HIV), NeuroAIDS",
author = "Buch, {Shilpa J} and Chivero, {Ernest T.} and Jackie Hoare and Jibreel Jumare and Noeline Nakasujja and Victor Mudenda and Robert Paul and Kanmogne, {Georgette D} and Ned Sacktor and Charles Wood and Walter Royal and Jeymohan Joseph",
year = "2016",
month = "10",
day = "1",
doi = "10.1007/s13365-016-0467-y",
language = "English (US)",
volume = "22",
pages = "699--702",
journal = "Journal of NeuroVirology",
issn = "1355-0284",
publisher = "Springer New York",
number = "5",

}

TY - JOUR

T1 - Proceedings from the NIMH symposium on “NeuroAIDS in Africa

T2 - neurological and neuropsychiatric complications of HIV”

AU - Buch, Shilpa J

AU - Chivero, Ernest T.

AU - Hoare, Jackie

AU - Jumare, Jibreel

AU - Nakasujja, Noeline

AU - Mudenda, Victor

AU - Paul, Robert

AU - Kanmogne, Georgette D

AU - Sacktor, Ned

AU - Wood, Charles

AU - Royal, Walter

AU - Joseph, Jeymohan

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Despite major advances in HIV-1 treatment, the prevalence of HIV-associated neurocognitive disorders (HAND) remains a problem, particularly as individuals on suppressive treatment continue to live longer. To facilitate discussion on emerging and future directions in HAND research, a meeting was held in Durban, South Africa in March 2015 as part of the Society of Neuroscientists of Africa (SONA) conference. The objective of the meeting was to assess the impact of HIV subtype diversity on HAND and immunological dysfunction. The meeting brought together international leaders in the area of neurological complications of HIV-1 infection with special focus on the African population. Research presentations indicated that HAND was highly prevalent and that inflammatory cytokines and immune-activation played important roles in progression of neurocognitive impairment. Furthermore, children on antiretroviral therapy were also at risk for developing neurocognitive impairment. With respect to the effect of HIV-1 subtype diversity, analyses of HIV-1 clade C infection among South Africans revealed that clade C infection induced cognitive impairment that was independent of the substitution in HIV-1 Trans-Activator of Transcription (Tat; C31S). At the cellular level, a Zambian study showed that clade C infection resulted in reduced brain cell death compared with clade B infection suggesting clade specific variations in mediating brain cell injury. Furthermore, ex vivo Tat protein from clade CRF02_AG, prevalent in West/ Central Africa, exhibited reduced disruption of brain endothelium compared with clade B Tat protein. Discussions shed light on future research directions aimed at understanding biomarkers and disease mechanisms critical for HAND.

AB - Despite major advances in HIV-1 treatment, the prevalence of HIV-associated neurocognitive disorders (HAND) remains a problem, particularly as individuals on suppressive treatment continue to live longer. To facilitate discussion on emerging and future directions in HAND research, a meeting was held in Durban, South Africa in March 2015 as part of the Society of Neuroscientists of Africa (SONA) conference. The objective of the meeting was to assess the impact of HIV subtype diversity on HAND and immunological dysfunction. The meeting brought together international leaders in the area of neurological complications of HIV-1 infection with special focus on the African population. Research presentations indicated that HAND was highly prevalent and that inflammatory cytokines and immune-activation played important roles in progression of neurocognitive impairment. Furthermore, children on antiretroviral therapy were also at risk for developing neurocognitive impairment. With respect to the effect of HIV-1 subtype diversity, analyses of HIV-1 clade C infection among South Africans revealed that clade C infection induced cognitive impairment that was independent of the substitution in HIV-1 Trans-Activator of Transcription (Tat; C31S). At the cellular level, a Zambian study showed that clade C infection resulted in reduced brain cell death compared with clade B infection suggesting clade specific variations in mediating brain cell injury. Furthermore, ex vivo Tat protein from clade CRF02_AG, prevalent in West/ Central Africa, exhibited reduced disruption of brain endothelium compared with clade B Tat protein. Discussions shed light on future research directions aimed at understanding biomarkers and disease mechanisms critical for HAND.

KW - HIV-associated neurocognitive disorders (HAND)

KW - Human immunodeficiency virus (HIV)

KW - NeuroAIDS

UR - http://www.scopus.com/inward/record.url?scp=84980044692&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84980044692&partnerID=8YFLogxK

U2 - 10.1007/s13365-016-0467-y

DO - 10.1007/s13365-016-0467-y

M3 - Article

C2 - 27473196

AN - SCOPUS:84980044692

VL - 22

SP - 699

EP - 702

JO - Journal of NeuroVirology

JF - Journal of NeuroVirology

SN - 1355-0284

IS - 5

ER -